BRANDY DAVIS: Open Payments
NPI 1184200347 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,295 in 60 payments from 18 companies in 2025. Trend: 2023 $43 · 2024 $1,011 · 2025 $1,295
Food & beverage: $1,295
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $208 |
| AstraZeneca Pharmaceuticals LP | 4 | $207 |
| ABBVIE INC. | 14 | $196 |
| Lilly USA, LLC | 7 | $130 |
| Saluda Medical Americas, Inc. | 2 | $94 |
| Novo Nordisk Inc | 5 | $87 |
| GlaxoSmithKline, LLC. | 4 | $72 |
| Axsome Therapeutics, Inc. | 3 | $63 |
| Neurocrine BioSciences, Inc. | 2 | $53 |
| Abbott Laboratories | 1 | $30 |
Products named: CAPLYTA, BREZTRI, MOUNJARO, QULIPTA, Evoke, VRAYLAR, Auvelity, AIRSUPRA.
Industry payments across LA — which companies pay providers there.
